Navigation Links
'Surgery' looks at inventions and innovations by surgeons
Date:3/6/2008

Philadelphia, PA, March 6, 2008 Surgeons are uniquely positioned to recognize areas for improvement in patient care and to develop innovative solutions to meet those needs. However, even the most productive surgical researchers may lack the know-how to develop their insights into successful commercial products. A special symposium in the February issue of SURGERY (Volume 143, Number 2, February 2008) provides surgeons with expert insights into the process of developing their ideas into commercially viable products that will benefit large numbers of patientswhile providing a financial return to inventors, investors, and university research departments.

Invited by the editors of SURGERY (http://www.elsevier.com/wps/find/journaldescription.cws_home/623195/description#description), the symposium includes contributions from a cross-section of experts, including noted experts in copyright and intellectual property, technology transfer, biomedical engineering, and finance, as well as from surgeons experienced in translating research ideas into the marketplace.

With mounting financial pressures academic medical centers are seeking new ways to support their missions of education, patient care, and research. A key initial question is whether the idea is patentablethat is, truly new, useful, and non-obvious. Once an idea with commercial potential is recognized, it must be developed through the complex processes leading to commercialization.

The eleven articles in the symposium emphasize that surgeons who invent new products provide a positive service, bringing valuable ideas from concept to the patient's bedside. Without the arduous and painstaking process of commercializationincluding finding investors willing to take the financial risk of funding new technologiesinnovative techniques of clinical value will never be developed to the scale at which they can benefit large numbers of patients.

For surgeon-researchers used to academic freedom and research for its own sake, collaborating with industry raises some unaccustomed issues. An overarching issue is conflict of interest. Today, universities have strict policies regarding potential financial conflicts of interest. These policies play an essential role in minimizing research bias and protecting patients serving as research subjects. However, one article in the symposium argues that an obsessive focus on conflict-of-interest disclosures hinders the development of beneficial research and innovations.

The development of new health science technologies offers a rare combination of potentially large financial returns with true health care advances with a significant impact on patients. In an introductory note, SURGERY Co-Editors-in-Chief Andrew L. Warshaw and Michael G. Sarr write, "The Editors offer this compendium, evidence of a changing academic world, in the hopes that our novel, imaginative, and innovative nuggets will be recognized and their value realized."


'/>"/>

Contact: Maureen Hunter
m.hunter@elsevier.com
215-239-3671
Elsevier
Source:Eurekalert

Related medicine news :

1. Neurologic & Orthopedic Hospital of Chicago Ranked Among Top in Nation for Spine Surgery
2. Independent Survey Names CyberKnife(R) System Most Widely Used Extracranial Radiosurgery Technology
3. Risk of surgery for lung cancer lower at teaching hospitals
4. Orthocrat Teams up With WebOps to Advance Orthopedic Pre-Surgery Planning
5. Scientists discover who is likely to get dry eye syndrome after LASIK surgery
6. Obese Children Face More Complications During Surgery
7. Mouse study: Real-time imaging device may improve surgery for congenital colon disease
8. Facial asymmetry persists despite surgery to correct congenital deformity
9. The danger of blindness after ophthalmic surgery
10. New York Plastic Surgeon Performs Pro Bono Surgery on Disadvantaged Patient Where Health Insurance Coverage Was Denied
11. Study finds spine surgery yields greater benefits over nonsurgical treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... “Christmas in Suffolk”: a story of love, secrets, and ... in Lafayette, Indiana where she works in a daycare and looks for inspiration in ... by Christian Faith Publishing, Sara Seymour’s new book is an adventure of love and ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Knowledge is God’s Lighthouse”: ... faith. “Knowledge is God’s Lighthouse” is the creation of published author, Gene Gaapf, a ... poetry collections. , “I have been writing since high school and have many ...
(Date:1/20/2017)... ... , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation of ... Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native who ... Hardy , “While sitting up in bed, I felt a pounding headache. It was ...
(Date:1/19/2017)... ... January 19, 2017 , ... Aerolib Healthcare ... for Clinical and Regulatory education for Physicians, Physician Advisors, Case managers, Utilization ... methodology of Disease Specific Documentation Improvement. , The Aerolib Learning Management System ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... 5,000 SF expansion and facility enhancement of their 503A compounding pharmacy located in ... the growing demand of physicians and patients throughout the United States for high-quality ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017 This report on the opioid induced ... of the global market. Large number of chronic pain ... constipation is a major side effect of consumption of ... targeted therapy has been prescribed to treat opioid induced ... medicines, and growing awareness about the therapy are the ...
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... Shire plc (LSE: SHP, NASDAQ: ... and Drug Administration (FDA) has acknowledged receipt of the ... for SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. ... for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to ... the designated Prescription Drug User Fee Act (PDUFA) action ...
Breaking Medicine Technology: